Clinical trials in Russia, Ukraine and Eastern Europe - Full-service CRO - Global Clinical Trials - GCT



• Princeton, NJ, USA • St. Petersburg, Russia • Moscow, Russia • Kiev, Ukraine • Sofia, Bulgaria • Bucharest, Romania		GCT is a CRO with operations in Russia, former Soviet Republics and Eastern Europe. GCT is headquartered in Princeton, NJ, USA with full service offices in St. Petersburg and Moscow, Russia; Sofia, Bulgaria; Bucharest, Romania and Kiev, Ukraine.
Current location: Main page Main Page About Corporate profile Experience Ethics Clinical research Services Coverage and country-specific info Global coverage Official links In focus News archive Participate with us Contact Offices Join our team Log in Web Mail Project Databases Groupware Sign up to meet our representativesChoose a meeting to proceed: ISCTM 8^th Annual Scientific Meeting The Ritz-Carlton, Washington, DC, USA 2012, February, 21—23 ASENT 14^th Annual Meeting Ritz-Carlton, Washington, DC, USA 2012, February, 22—25 DIA 24^th Annual EuroMeeting Copenhagen, Denmark 2012, March, 26—28 3^rd Biennial Schizophrenia International Research Conference Florence, Italy 2012, April, 14—18 12^th International Symposium on Advances in Alzheimer Therapy City Conference Centre, Stockholm, Sweden 2012, May, 09—12 NCDEU 2012 meeting Arizona Biltmore Resort and Spa, Phoenix, Arizona, USA 2012, May, 29 — June, 01 28^th CINP World Congress of Neuropsychopharmacology Stockholmsmässan, Stockholm, Sweden 2012, June, 03—07 AAIC 2012 Vancouver, British Columbia, Canada 2012, July, 14—19 ESSSB 14 Tel Aviv, Israel 2012, September, 03—06 ISCTM Autumn Conference The Ritz-Carlton, Marina del Rey, California, USA 2012, October, 02—03 ECNP Congress Vienna, Austria 2012, October, 13—17 5^th CTAD Grimaldi Forum Convention Center, Monte Carlo 2012, October, 29—31 CNS Summit 2012 Boca Raton Resort and Club, Boca Raton, Florida, USA 2012, November, 15—18 ACNP 2012 The Westin Diplomat, Hollywood, Florida, USA 2012, December, 02—06 Reach us: +1 609 921 6868 (USA) info@gctrials.com More contact info here.	January News Dermatology Project GCT executed contract for the conduct of Phase III Rosacea trial at five sites in Bulgaria for the dermatology - oriented pharmaceutical company. New Global Oncology Project Harvard Medical School is one of the sites for the Project. Despite being mostly European CRO, GCT has been contracted to monitor several large oncology sites in the US for the upcoming international project. We are also responsible for 15 sites in Russia on the same study. This is already second trial GCT is monitoring in the US within the last year. January 2012; Princeton, USA Oncology project Micrograph of mantle cell lymphoma, a type of non-Hodgkin lymphoma. We are joining a multi-center, multi-national Phase III clinical study in Non-Hodgkin lymphoma conducted in Eastern Europe and India. GCT will be responsible for the study conduct in Ukraine. With the very rare target patient population, this study will be a proof of our expertise in oncohematology trials. November 2011; St. Petersburg, Russia Global project Ultrasonic examination during pregnancy Global Clinical Trials has been awarded a clinical trial project for the prevention of pre-term birth. This Global program which includes sites located in the United States, Canada, Italy, Spain, Hungary, Czech Republic, Ukraine and Russia is being managed through ResearchPoint Global. RPG is a worldwide clinical organisation with 21 offices and clinical coverage In over 60 countries. Global Clinical Trials is one of the founding members of this organisation established in 2004. Global Clinical Trials is responsible for 23 sites located in Hungary, Czech Republic, Russia and Ukraine, enrolling more than 550 subjects. October 2011; St. Petersburg, Russia Rusnanotech 2011 Dr. Eugene Selivra making his speech at Rusnanoforum 2011 The CEO of Global Clinical Trials, Dr. Eugene Selivra, was invited to chair the "Key Aspects of Clinical Trials in Russia" session and the round table discussion during the upcoming Rusnanotech 2011 - International Nanotechnology Forum to be held in Moscow on October 26-28, 2011. The Rusnanotech Forum is one of the central events of the year in the field of innovation in Russia. When asked about his involvement in the upcoming forum, Dr. Selivra said "Global Clinical Trials' association with RUSNANO further demonstrates our ongoing commitment to the advancement of the pharmaceutical industry in the Russian Federation and bringing together international research and investment communities from around the world. We are honored to be involved in such an innovative and forward looking conference." Arrange a meeting at this event. September 2011; Moscow, Russia Regulatory submission Kiev Central Clinical Hospital. GCT made regulatory submission for approval of psoriasis clinical study to be conducted at 6 sites in Ukraine for the top international pharmaceutical company. Conference GCT President Dr. Jeffrey Apter will be presenting at Rational Pharmacotherapy Conference held in St. Petersburg, Russia on October 12- 14, 2011 sponsored by the Health Committee of the Government of St. Petersburg. August 2011; Kiev, Ukraine June news White Nights White Nights Ophthalmology Congress — plenary section. Global Clinical Trials was once again heavily involved in the "White Nights Ophthalmology Congress" held each May in St. Petersburg, Russia. GCT has been a Partner of the congress since 2006, managing and maintaining the conference website and registration system. Our relationship with the Congress exhibition and our role in the success of the meeting provides us exclusive access to the registration information. This affords GCT a truly unique gateway to the ophthalmological community of the Region allowing us to maintain an active and relevant database of potential sites and thought leaders within the therapeutic area. The relationships we have developed with the sites through our interaction within the meeting and our work with them individually has established GCT as the CRO of choice for the leading pharmaceutical and biotech ophthalmology companies worldwide and ophthalmologists in Russia and throughout the region. Oncology program Global Clinical Trials has executed the agreement with a reputed biotechnology company from California for conduct of Phase II oncology program in Eastern Europe and Russia. June 2011; St. Petersburg, Russia May news New project in ophthalmology We have initiated enrollment in one of our multi-national ophthalmology trials conducted in the Region. This trial, placed in Russia for inadequately controlled ocular hypertension or glaucoma, is being conducted for one of the largest ophthalmology companies in the world. This trial is one of several trials we have already conducted with this client. Audit GCT is proud to announce that we have successfully completed our 31^st client audit on behalf of one of the top 10 pharmaceutical companies in the world. This audit included review of our processes and SOPs for our GCT office facilities and the drug storage facility. The audit was completed with no major findings. May 2011; St. Petersburg, Russia Previous postings New project in Russia and US Regulatory approvals Steady recruitment Alzheimer's programs New Ophthalmology program Ophthalmology project Psoriasis program Older postings are in the archive

© Global Clinical Trials, LLC